Global Rilutek Market Insights, Forecast to 2030

Publication ID:

PB512241223

Publication Date:

December 27, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Rilutek is a drug used to treat amyotrophic lateral sclerosis.
The global Rilutek market is projected to grow from US$ 41 million in 2024 to US$ 38 million by 2030, at a Compound Annual Growth Rate (CAGR) of -1.2% during the forecast period.
The amyotrophic lateral sclerosis (ALS) therapeutics market is driven by the increasing prevalence of ALS and the growing demand for effective treatments to slow disease progression and improve patient outcomes. As the understanding of ALS pathophysiology improves, researchers and pharmaceutical companies are actively exploring novel therapeutic approaches, including gene therapies and immune-modulating agents. The approval of new ALS drugs and the development of combination therapies further propel market growth. However, challenges include the complexity of ALS as a multi-factorial disease, the difficulty in diagnosing ALS at an early stage, and the high cost of drug development and clinical trials. Addressing these challenges through collaborative research, improved diagnostic tools, and accessible treatment options will be crucial for the sustained growth of the ALS therapeutics market.
Report Covers:
This report presents an overview of global market for Rilutek, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Rilutek, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Rilutek, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rilutek sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Rilutek market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Rilutek sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
Italfarmaco
Segment by Type
With Film-coated
Without Film-coated
Segment by Application
Hospital
Pharmacy
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Rilutek in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Rilutek manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rilutek sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Rilutek Product Introduction
1.2 Market by Type
1.2.1 Global Rilutek Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 With Film-coated
1.2.3 Without Film-coated
1.3 Market by Application
1.3.1 Global Rilutek Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rilutek Sales Estimates and Forecasts 2019-2030
2.2 Global Rilutek Revenue by Region
2.2.1 Global Rilutek Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Rilutek Revenue by Region (2019-2024)
2.2.3 Global Rilutek Revenue by Region (2025-2030)
2.2.4 Global Rilutek Revenue Market Share by Region (2019-2030)
2.3 Global Rilutek Sales Estimates and Forecasts 2019-2030
2.4 Global Rilutek Sales by Region
2.4.1 Global Rilutek Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Rilutek Sales by Region (2019-2024)
2.4.3 Global Rilutek Sales by Region (2025-2030)
2.4.4 Global Rilutek Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rilutek Sales by Manufacturers
3.1.1 Global Rilutek Sales by Manufacturers (2019-2024)
3.1.2 Global Rilutek Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rilutek in 2023
3.2 Global Rilutek Revenue by Manufacturers
3.2.1 Global Rilutek Revenue by Manufacturers (2019-2024)
3.2.2 Global Rilutek Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rilutek Revenue in 2023
3.3 Global Key Players of Rilutek, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Rilutek Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rilutek Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rilutek, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rilutek, Product Offered and Application
3.8 Global Key Manufacturers of Rilutek, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rilutek Sales by Type
4.1.1 Global Rilutek Historical Sales by Type (2019-2024)
4.1.2 Global Rilutek Forecasted Sales by Type (2025-2030)
4.1.3 Global Rilutek Sales Market Share by Type (2019-2030)
4.2 Global Rilutek Revenue by Type
4.2.1 Global Rilutek Historical Revenue by Type (2019-2024)
4.2.2 Global Rilutek Forecasted Revenue by Type (2025-2030)
4.2.3 Global Rilutek Revenue Market Share by Type (2019-2030)
4.3 Global Rilutek Price by Type
4.3.1 Global Rilutek Price by Type (2019-2024)
4.3.2 Global Rilutek Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Rilutek Sales by Application
5.1.1 Global Rilutek Historical Sales by Application (2019-2024)
5.1.2 Global Rilutek Forecasted Sales by Application (2025-2030)
5.1.3 Global Rilutek Sales Market Share by Application (2019-2030)
5.2 Global Rilutek Revenue by Application
5.2.1 Global Rilutek Historical Revenue by Application (2019-2024)
5.2.2 Global Rilutek Forecasted Revenue by Application (2025-2030)
5.2.3 Global Rilutek Revenue Market Share by Application (2019-2030)
5.3 Global Rilutek Price by Application
5.3.1 Global Rilutek Price by Application (2019-2024)
5.3.2 Global Rilutek Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Rilutek Market Size by Type
6.1.1 US & Canada Rilutek Sales by Type (2019-2030)
6.1.2 US & Canada Rilutek Revenue by Type (2019-2030)
6.2 US & Canada Rilutek Market Size by Application
6.2.1 US & Canada Rilutek Sales by Application (2019-2030)
6.2.2 US & Canada Rilutek Revenue by Application (2019-2030)
6.3 US & Canada Rilutek Market Size by Country
6.3.1 US & Canada Rilutek Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Rilutek Sales by Country (2019-2030)
6.3.3 US & Canada Rilutek Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rilutek Market Size by Type
7.1.1 Europe Rilutek Sales by Type (2019-2030)
7.1.2 Europe Rilutek Revenue by Type (2019-2030)
7.2 Europe Rilutek Market Size by Application
7.2.1 Europe Rilutek Sales by Application (2019-2030)
7.2.2 Europe Rilutek Revenue by Application (2019-2030)
7.3 Europe Rilutek Market Size by Country
7.3.1 Europe Rilutek Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Rilutek Sales by Country (2019-2030)
7.3.3 Europe Rilutek Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rilutek Market Size
8.1.1 China Rilutek Sales (2019-2030)
8.1.2 China Rilutek Revenue (2019-2030)
8.2 China Rilutek Market Size by Application
8.2.1 China Rilutek Sales by Application (2019-2030)
8.2.2 China Rilutek Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Rilutek Market Size by Type
9.1.1 Asia Rilutek Sales by Type (2019-2030)
9.1.2 Asia Rilutek Revenue by Type (2019-2030)
9.2 Asia Rilutek Market Size by Application
9.2.1 Asia Rilutek Sales by Application (2019-2030)
9.2.2 Asia Rilutek Revenue by Application (2019-2030)
9.3 Asia Rilutek Sales by Region
9.3.1 Asia Rilutek Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Rilutek Revenue by Region (2019-2030)
9.3.3 Asia Rilutek Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rilutek Market Size by Type
10.1.1 Middle East, Africa and Latin America Rilutek Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Rilutek Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Rilutek Market Size by Application
10.2.1 Middle East, Africa and Latin America Rilutek Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Rilutek Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Rilutek Sales by Country
10.3.1 Middle East, Africa and Latin America Rilutek Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Rilutek Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Rilutek Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Rilutek Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Sanofi Rilutek Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Mylan Pharma
11.2.1 Mylan Pharma Company Information
11.2.2 Mylan Pharma Overview
11.2.3 Mylan Pharma Rilutek Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Mylan Pharma Rilutek Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mylan Pharma Recent Developments
11.3 Apotex
11.3.1 Apotex Company Information
11.3.2 Apotex Overview
11.3.3 Apotex Rilutek Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Apotex Rilutek Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Apotex Recent Developments
11.4 Glemark Generics
11.4.1 Glemark Generics Company Information
11.4.2 Glemark Generics Overview
11.4.3 Glemark Generics Rilutek Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Glemark Generics Rilutek Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Glemark Generics Recent Developments
11.5 Covis Pharma
11.5.1 Covis Pharma Company Information
11.5.2 Covis Pharma Overview
11.5.3 Covis Pharma Rilutek Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Covis Pharma Rilutek Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Covis Pharma Recent Developments
11.6 Sun Pharma
11.6.1 Sun Pharma Company Information
11.6.2 Sun Pharma Overview
11.6.3 Sun Pharma Rilutek Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Sun Pharma Rilutek Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sun Pharma Recent Developments
11.7 Lunan Pharma
11.7.1 Lunan Pharma Company Information
11.7.2 Lunan Pharma Overview
11.7.3 Lunan Pharma Rilutek Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Lunan Pharma Rilutek Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lunan Pharma Recent Developments
11.8 Italfarmaco
11.8.1 Italfarmaco Company Information
11.8.2 Italfarmaco Overview
11.8.3 Italfarmaco Rilutek Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Italfarmaco Rilutek Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Italfarmaco Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rilutek Industry Chain Analysis
12.2 Rilutek Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rilutek Production Mode & Process
12.4 Rilutek Sales and Marketing
12.4.1 Rilutek Sales Channels
12.4.2 Rilutek Distributors
12.5 Rilutek Customers
13 Market Dynamics
13.1 Rilutek Industry Trends
13.2 Rilutek Market Drivers
13.3 Rilutek Market Challenges
13.4 Rilutek Market Restraints
14 Key Findings in The Global Rilutek Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Companies Mentioned:

Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
Italfarmaco

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂